GeneDx Holdings Corp. (WGSWW)

Market Cap	3.10B
Revenue (ttm)	305.45M
Net Income (ttm)	-52.29M
Shares Out	27.78M
EPS (ttm)	-1.94
PE Ratio	n/a
Forward PE	136.16
Dividend	n/a
Ex-Dividend Date	n/a

Volume	195,660
Open	0.220
Previous Close	0.230
Day's Range	0.220 - 0.279
52-Week Range	0.220 - 0.279
Beta	2.18
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 18, 2025

About WGSWW

GeneDx Holdings Corp., a genomics company, provides personalized and actionable health insights to inform diagnosis, direct treatment, and improve drug discovery. The company accelerate the use of genomics and leverage clinical data to enable precision medicine as the standard of care. It utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process DNA-containing samples, analyzes information about patient-specific genetic variation, and generates test reports for clinicians and their patient...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2017
• Employees: 1,000
• Stock Exchange: NASDAQ
• Ticker Symbol: WGSWW
• Website: https://www.genedx.com

Financial Performance

In 2024, GeneDx Holdings's revenue was $305.45 million, an increase of 50.79% compared to the previous year's $202.57 million. Losses were -$52.29 million, -70.25% less than in 2023.